PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328968
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1328968
The Latin American dental bone graft substitute and other biomaterials market exhibited a value of $206 million in 2022. Projections indicate a robust growth trajectory during the forecast period, with an anticipated Compound Annual Growth Rate (CAGR) of 16.5%, driving the market value to almost $599 million. Presently, this market is dominated by three prominent contenders: Geistlich, Straumann Group, and Bioinnovation.
Our comprehensive medical market research delved into the dynamics of over 28 companies across Latin America. Employing a rigorous methodology, we discerned the intricacies of market sizes, unit sales, company market shares, and meticulously crafted accurate forecasts. The comprehensive report suite on the Latin American dental bone graft substitute and other biomaterials market encompasses segments like Dental Bone Graft Substitute, Dental Barrier Membrane Market, and Antimicrobial Periodontal Treatment Markets.
Within Latin America, a persistent trend of off-label sales has emerged, offering seemingly premium products at notably reduced costs. These unauthorized deals have garnered a significant customer base, leveraging the allure of cost savings, a critical factor in the region's economically fragile landscape. The extent of this trend is likely substantial, although precise volume estimation remains challenging due to the covert and unreported nature of these transactions. The appeal of off-label alternatives extends beyond just affordability; it's also a response to the market's perceived over-regulation. To sidestep the bureaucratic hurdles associated with legitimate bone graft acquisition, off-label products offer an enticing workaround. Notably, these unapproved brands flourish primarily within the xenograft and synthetic segments. For instance, a replica of Geistlich's Bio-Oss® has gained traction. This influx of imitation products significantly dampens the overall Average Selling Price (ASP) of bone graft substitutes. As customers increasingly gravitate towards off-label options, the potential of the market is further encumbered by the fierce competition these brands bring. Emerging entrants encounter off-label sales as their primary adversary, a challenge that can prove formidable to overcome.
In the Latin American dental biomaterials market, Geistlich claims the forefront, particularly in Brazil. Here, it exerts remarkable influence across the dental bone graft substitute and dental barrier membrane sectors, propelled by its acclaimed Bio-Oss® bovine xenograft and Bio-Gide® collagen membrane product offerings. While regional contenders proposing more economical xenografts and porcine collagen membranes may pose rivalry, Geistlich is poised to retain its dominant market stance. Pursuing closely is the Straumann Group, strategically collaborating with botiss, thereby entering the dental barrier membrane arena and securing substantial market presence. Bolstered by a robust operational framework and an extensive product range, Straumann Group capitalizes on its esteemed repute and steadfast clientele. In the third-ranking position emerges Bionnovation, a Brazilian enterprise distinguished for its prowess across dental implant, biomaterials, and dental instrumentation domains. The proprietary Bonefill® Osso Bovino, an inorganic demineralized matrix, garners recognition for accelerating bone repair. Simultaneously, the surgitime® lineup, catering to diverse patient requisites, underscores its prowess within the dental barrier membrane segment. Bionnovation is poised to uphold its market standing over the projected period.
List of Charts
List of Figures